Dr. Heleen Riper Innovation Centre of Mental Health & Technology Sustainable prevention with e-mental health INPES April 2010.

Slides:



Advertisements
Similar presentations
Raising the priority of noncommunicable diseases in development work at global and national levels Presentation for discussion (Not an official document)
Advertisements

1 Translation of Research Findings for Prevention and Control of NCDs Shanthi Mendis Chronic Disease Prevention and Management World Health Organization.
MICS4 Survey Design Workshop Multiple Indicator Cluster Surveys Survey Design Workshop Questionnaire for Children Under Five: Malaria.
Cancer Control in the EMR Dr. Haifa Madi Director, Health Protection and Promotion WHO/EMRO.
noncommunicable diseases
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Country presentation - Kenya
Improving Depression Treatment in Primary Care: Dissemination and Implementation Edmund Chaney, PhD Department of Veterans Affairs, Seattle AcademyHealth.
1 Health Needs of Refugees Gilbert Burnham, MD, PhD Johns Hopkins University.
Cannabis Treatment Demand in Canada Dr. Brian RushKaren Urbanoski Dr. Carol StrikeMarion Mueller Health Systems Research and Consulting Unit Centre for.
Health Statistics and Informatics Global Burden of Disease 2004 Update: Selected figures and tables Health Statistics and Informatics Department.
© WHO, U n i t 1 Magnitude and impact of road traffic injuries.
GARD Global Alliance against Chronic Respiratory Diseases WHO J Bousquet, R Dahl, N Khaltaev, HJ Bekedam.
1 1  1 =.
Year 6 mental test 5 second questions
Year 6 mental test 10 second questions
Non Communicable Diseases (NCDs) In Kuwait
Fogarty International Center of the U. S
What to include? Should EDCTP-2 be expanded to other fields? Marja Esveld, 29 September 2010.
Chapter 3. Most degenerative diseases are caused, at least in part, by our modern diet About 60 million adults, or 30% of the adult population, are now.
Jonathan B. Bricker, PhD Fred Hutchinson Cancer Research Center University of Washington Telephone-Delivered ACT for Adult Smoking Cessation: A Feasibility.
Improving Health Through Medical Education David G. Nichols, MD Johns Hopkins University School of Medicine Johns Hopkins Medicine International Partners.
Stroke Management in Developing Countries Junaid A. Razzak MD PhD FACEP Chief, Section of Emergency Medicine Aga Khan University Karachi, Pakistan.
2012 / 2013 Benefits Open Enrollment Murray School District.
Chronic Disease Prevention and Management Why is this focus area important? Chronic disease such as heart disease, stroke, cancer, diabetes and arthritis.
Nurse Led Clinics Opportunity for nurses to make a difference Wilma Scholte op Reimer, RN, PhD Amsterdam School of Health Professions Academic Medical.
AHS IV Trivia Game McCreary Centre Society
Chris Bonnett, MHSc, PhD (Cand.) H3 Consulting, Guelph Managing Chronic Disease Can it work at work?
TOWARDS UNIVERSAL ACCESS
Minnesota Department of Health Tuberculosis Prevention and Control Program (651) Tuberculosis surveillance data for Minnesota are available on.
Asia Maselko and Kristen Shirey 01 October
WASH Cluster – Emergency Training D D1 1 WASH Related Diseases Session 1 The Environmental Burden of Disease.
Development, creative industries, democracy and Africa
Figure Essential Cell Biology (© Garland Science 2010)
Slide 1 of 22 IAS–USA Victor G. Valcour, MD Professor of Geriatric Medicine University of California San Francisco Emerging Issues in HIV, Aging, and Cognition.
Diabetes: Public Health Implications Dr. Bruce Goodrow East Tennessee State University.
Institute for Public Health, Medical Decision Making and Health Technology Assessment 1 Results of the PanEuropean Hepatitis C Project 3 rd Paris Hepatitis.
Click the arrows to advance forward and backward. Click the Next link below to advance to the assessment. The A B C & D’s of Suicide Assessment and Clinical.
Rhode Island’s Health ─ 2012 Michael Fine, MD Director of Health.
When, how and which patient to treat with HBV infection. David Mutimer Queen Elizabeth Hospital Birmingham, England. BSG Post-graduate Course March 20.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 4.
Is HIV/AIDS still exceptional? Alan Whiteside Health Economics and HIV/AIDS Research Division, University of KwaZulu-Natal Durban Presentation to Daniel.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
International Council of Ophthalmology The Cost Utility of Eye Care and the ICO Advocacy Program Hugh R. Taylor, AC ICO Director for Advocacy Luncheon.
Injury Epidemiology An Introduction readings Thomas Songer, PhD University of Pittsburgh.
Health Status of Australian Adults. The health status of Australians is recognised as good and is continually improving. The life expectancy for males.
BOD working group BURDEN OF DISEASE IN THAILAND, 2009.
Terms: Epidemiologic Transition Gaziano 2005 Stage 1Malnutrition and infectious diseases are the leading causes of mortality and morbidity Stage 2Improved.
Injuries and Violence Prevention: WHO's approach Injuries and Violence Prevention: WHO's approach Etienne Krug, MD, MPH Director, Department of Injuries.
International Health Policy Program -Thailand Phusit Prakongsai, MD. Ph.D. Walaiporn Patcharanarumol, MSc. Ph.D. Viroj Tangcharoensathien, MD. Ph.D. International.
The high costs of inactivity in Scotland (and England) Dr Charlie Foster BHF Health Promotion Research Group University of Oxford Physical Activity for.
Carbon monoxide and nitrogen dioxide in the atmosphere: A look at the effects on chronic obstructive pulmonary disease Carbon monoxide and nitrogen dioxide.
Joseph Perriëns MD, PhD Dept of HIV/AIDS World Health Organization
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
WORLD HEALTH ORGANIZATION Source: World Health Report 2000 JS 3/01 WHO Statistics, 2000 Dr. Rüdiger Krech A/Regional Adviser, Healthy Ageing World Health.
The Good…. The Bad…. & The Ugly.. What is disease?  How many diseases are there?  Diseases vs Conditions…  Types of diseases.
Sight loss and depression Tom Margrain Sharon Beckett.
Danish Health and Medicines Authority  Denmark Dr. Else Smith Chief Medical Officer and Director General National Board of Health Chronic diseases – a.
Similarities and differences between developing countries and Australia Chapter 8.2.
Geriatric education for PHC physicians – 1 st congress of the EU Geriatric Medicine society Paris, August 29 th -Sept.1 st, 2001 Dr. Rüdiger Krech A/Regional.
The Good…. The Bad…. & The Ugly.. Disease concepts  How many diseases are there?  Health, Function, Disability, Impairment, oh my!  Is it a disease.
Health Outcomes due to Alcohol 14 July 2005 Kanitta Bundhamcharoen MOPH.
The Global Burden of Injuries Thomas Songer, PhD University of Pittsburgh.
Headspace – an adolescent mental health service Nic Hubbard and Jeremy Swire.
Environmental Health and Toxicology Introductory Lecture.
Interventions and their benefits Prof. Dr. Pim Cuijpers
Global epidemiology of injecting drug use
WHO Statistics, 2000 Dr. Rüdiger Krech
HIV Viral Suppression Rate in U. S
CANARY HEALTH A population health company specializing in digital diabetes, heart, arthritis, depression, and other online programs for people with chronic.
Presentation transcript:

Dr. Heleen Riper Innovation Centre of Mental Health & Technology Sustainable prevention with e-mental health INPES April 2010

What woulddo?

What woulddo?

1 out of 4 mental health problem in lifetime

1 per 15 YP

1 million suicides per year

Disease burden in 2030 Worldwide % of total DALY Source: Mathers & Loncar, 2006 High-income countries Cataracts HIV/AIDS Depression Is. heart disease Road traffic Perinatal Cerebrovasculair COPD chest infections Hearing loss Alzheimer / dementias Depression Is. heart disease Alcohol Diabetes Cerebrovasculair Hearing loss Lung cancers / infections Ostearthritis COPD % of total DALY

more people less money transition chonic diseases self-management life style

health decisions are made by..

EMH costs treatment duration and intensity effect sizes small medium large mental fitness prevention treatment relapse prevention care population health gain large medium small © Riper 2008

Is it scalable from research into the Real World?

33% 73% 5% 60% Developing Developed World % mobile subs. 90% 25% 17% 5% Internet Penetration

StudyNTarget groupComp CYL/WL/ 12 wks* significant Spek d= 0.55 Warmerdam d= 0.69 De Graaf d= 0.20 Voordouw / d= 1.09 (Pre-post within) Color Your Life

Drinking Less

*P<0.001 Drinking Less Real World N= 378 ITT N/ RCT Target GroupSuccessful drinking at 6 months Successful drinking at 12 months 26114/21 SU Alcohol weekly and/or 6/4 per occasion 17,2% DL 5,4 % Control (p=.008) 13,6% DL 5,5% Control (p<.05) 18,8 %* 17,5 %* monthly visitors 1 out of 16 starts with DL Mean 40.9 (25.2 SD) SU Weekly AUDIT: M (sd 6.30) 6 months study period: N= 972 Response rate 39% Drop out 59% & 56%

Theory: 4 possible outcomes Modelling cost-effectiveness of eHealth interventions16 More costs Less effect Fewer costs Less effect More costs More effect Fewer costs More effect

Example 1: Self-help in depression Modelling cost-effectiveness of eHealth interventions17 Smit F, Willemse G, Koopmanschap M, Onrust S, Cuijpers P, Beekman A. (2006) Cost-effectiveness of preventing depression in primary care patients: randomised trial. British Journal of Psychiatry 188:

Example 2: eHealth v waitlist Modelling cost-effectiveness of eHealth interventions18

Example 3: eHealth v Group CBT Modelling cost-effectiveness of eHealth interventions19

Key messages Modelling cost-effectiveness of eHealth interventions20

low ses etnic cultural minorities recruitment acceptable interventions visual screener

Visual Screener

Visual Screener Depression, Anxiety &Alcohol Dutch N=86 Turkish N= How do you feel?depression0.39 r0.21 r 2. How did you feel in the past two weeks?depression0.47 r0.29 r 3. Do you worry a lot?GAD0.46 r0.30 r 4. Do you sometimes suddenly panic?Panic15.14 χ χ 2 5. Are you afraid of busy places that are difficult to leave? AGO0.53 χ 2 n.s.7.28 χ 2 6. Is there something that you are very afraid of? Specific Phobia χ χ 2 7. Are you afraid of being watched by people?Social Fobia χ χ 2 n.s. 8. Have you ever experienced something horrible? PTSD24.39 χ χ 2 9. Do you sometimes have unpleasant thoughts that wont go away? OCD5.58 χ χ 2 n.s. 10. Do you ever think about your own death?Alcohol0.70 r0.22 r 11. Do you ever think of killing yourself?Suicide23.47 χ χ 2 Validadion Visual Screener

effective scalable acceptable planned efforts knowledge turning point sustainable filling the gap health gain

thank you for your attention Heleen Riper